دوره 14، شماره 1 - ( 12-1404 )
جلد 14 شماره 1 صفحات 0-0 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Yazdian Robati R, Tabaripour R, Fakhar M, Ziaei Hezarjaribi H. Aptamer-Based Biosensors: Emerging Tools for Next-Generation Diagnosis of Strategic Parasitic Diseases. Res Mol Med (RMM) 2026; 14 (1)
URL: http://rmm.mazums.ac.ir/article-1-619-fa.html
URL: http://rmm.mazums.ac.ir/article-1-619-fa.html
Aptamer-Based Biosensors: Emerging Tools for Next-Generation Diagnosis of Strategic Parasitic Diseases. Research in Molecular Medicine. 1404; 14 (1)
چکیده: (23 مشاهده)
Parasitic diseases impose a profound global health and economic burden, particularly in resource-limited settings where rapid and accurate diagnostic infrastructure is lacking. Traditional diagnostic methods often fall short in sensitivity, specificity, and point-of-care adaptability. Aptamers—single-stranded DNA or RNA oligonucleotides selected in vitro via systematic evolution of ligands by exponential enrichment (SELEX)—have emerged as highly stable, cost-effective, and versatile biorecognition elements capable of binding diverse targets with high affinity and specificity. This review explored the mechanisms of aptamer-based biosensors (aptasensors) and their emerging applications in diagnosing strategic parasitic infections, including malaria, leishmaniasis, Chagas disease, Human African Trypanosomiasis, and giardiasis. Despite challenges, such as nuclease degradation and SELEX-related biases, aptamer-based biosensors demonstrate significant potential as reliable, sensitive, and specific tools for next-generation diagnosis and monitoring of parasitic diseases.
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
